Geode Capital Management LLC Acquires 251,823 Shares of Beyond Air, Inc. (NASDAQ:XAIR)

Geode Capital Management LLC grew its holdings in Beyond Air, Inc. (NASDAQ:XAIR) by 81.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 562,713 shares of the company’s stock after acquiring an additional 251,823 shares during the period. Geode Capital Management LLC owned 0.74% of Beyond Air worth $202,000 as of its most recent SEC filing.

Separately, Baldwin Wealth Partners LLC MA increased its stake in shares of Beyond Air by 721.3% in the 4th quarter. Baldwin Wealth Partners LLC MA now owns 308,000 shares of the company’s stock worth $110,000 after purchasing an additional 270,500 shares in the last quarter. Institutional investors own 31.50% of the company’s stock.

Insiders Place Their Bets

In other news, Director Robert Carey bought 1,000,000 shares of the stock in a transaction that occurred on Friday, March 14th. The shares were bought at an average price of $0.25 per share, for a total transaction of $250,000.00. Following the purchase, the director now owns 4,076,864 shares in the company, valued at $1,019,216. This represents a 32.50 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 20.10% of the company’s stock.

Beyond Air Stock Performance

NASDAQ XAIR opened at $0.20 on Friday. The business’s fifty day moving average is $0.25 and its 200 day moving average is $0.37. Beyond Air, Inc. has a fifty-two week low of $0.19 and a fifty-two week high of $1.49. The company has a market capitalization of $17.56 million, a PE ratio of -0.19 and a beta of 0.25.

Beyond Air (NASDAQ:XAIR) last posted its quarterly earnings data on Monday, February 10th. The company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.24) by $0.09. Beyond Air had a negative return on equity of 226.01% and a negative net margin of 1,730.00%. During the same period in the prior year, the company earned ($0.50) EPS. On average, sell-side analysts forecast that Beyond Air, Inc. will post -0.79 EPS for the current year.

Beyond Air Company Profile

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.